Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination
暂无分享,去创建一个
Hossam Abdel Rahman | G. Kang | T. Cherian | C. Ladva | J. Tate | J. Matthijnssens | L. Liying | A. Wasley | M. Iturriza-Gómara | Z. Mladenova | A. de Rougemont | E. Houpt | B. Manna | L. Bodhidatta | N. Batmunkh | J. Liyanage | M. Monini | G. Ruiz-Palacios | S. Becker-Dreps | R. Dagan | C. Sanderson | L. D. de Oliveira | T. Ochoa | C. Quach | F. Ntoumi | U. Heininger | P. Wijesinghe | E. Klein | A. Cohen | N. Henschke | D. Gendrel | M. Lorrot | S. Antoni | A. Page | C. Langendorf | A. Podkolzin | M. Agócs | A. Arana | J. McCracken | B. Lopman | K. Grimwood | A. Henao-Restrepo | X. Riveros | G. Cilla | D. Denno | Tomoka Nakamura | M. Motamedifar | D. Payne | D. Cheikh | I. Contreras-Roldan | C. Cordón-Rosales | N. Bhandari | D. Hungerford | K. Kotloff | N. Cunliffe | A. Clark | M. Montes | N. Givon | M. Wikswo | J. Mwenda | N. Page | B. Tagbo | M. Groome | G. Weldegebriel | S. Banajeh | P. Tarr | H. Yhu-Chering | C. Jarquín | K. Fox | A. Linhares | F. Serhan | D. Daniels | N. Kiulia | G. Rey-Benito | K. S. Ghenghesh | Q. Yuan | A. Turner | K. Sugata | T. Braeckman | L. Soares | T. Krishnan | M. Mathew | S. De Grazia | F. Paladin | H. Ahmed | J. Bwogi | E. Wandera | R. Latipov | M. Rácz | T. Yoshikawa | S. FLETCHER-LARTEY | P. Kaiser-Labusch | J. Biey | M. Alkorta | E. Uzoma | M. Mandile | J. Nokes | J. Degiuseppe | A. F. Athiyyah | S. M. Sudarmo | Dovile Videbaek | N. Teleb | M. Hasso-Agopsowicz | J. Murray | R. de Cássia Compagnoli Carmona | Simarjit Singh | K. Zaman | N. J. Sanwogou | M. Benhafid | S. Dutta | S. Kar | Varja Grabovac | C. O'Reilly | B. Coulson | C. Atchison | J. Díaz | S. Satter | M. C. S. S. M. N. L. T. J. R. G. I. B. N. A. R. N. J. I. S. Z. J. S. T. B. S. Alkorta Atchison Banaj | S. Dhiman | Z. Dian | C. Fu | G. Gonzalez Mago | A. Haque | I. L. Contreras | C. Mast | F. Matinon-Torres | A. Najafi | T. Nelson | K. Numazaki | S. Saha | K. Shigemura | T. Shirakawa | R. R. Vatosoa | X. Zhou | S. X. Zhang | W. Xu | S. Sudarmo
[1] Mercy Mvundura,et al. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC , 2020, PloS one.
[2] J. Tate,et al. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study , 2019, The Lancet. Global health.
[3] M. Jit,et al. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules , 2019, The Lancet. Global health.
[4] M. Jit,et al. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials , 2019, The Lancet. Infectious diseases.
[5] K. Neuzil,et al. Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants , 2018, The Journal of infectious diseases.
[6] Katherine J. Lee,et al. Human neonatal rotavirus vaccine (RV3-BB) targets rotavirus from birth , 2018, The New England journal of medicine.
[7] E. Burnett,et al. Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality. , 2017, Vaccine.
[8] G. Kang,et al. Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements , 2017, PloS one.
[9] G. Kang,et al. Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies , 2017, The Journal of infectious diseases.
[10] A. Steele,et al. The rotavirus vaccine development pipeline , 2017, Vaccine.
[11] L. Lamberti,et al. A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years , 2016, The Pediatric infectious disease journal.
[12] J. Read,et al. In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[13] Mark A. Miller,et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). , 2015, The Lancet. Global health.
[14] Inacio Mandomando,et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.
[15] Manish M Patel,et al. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. , 2013, The Journal of infectious diseases.
[16] G. Kang,et al. Protective effect of natural rotavirus infection in an Indian birth cohort. , 2011, The New England journal of medicine.
[17] R. Glass,et al. Rotavirus infection in infants as protection against subsequent infections. , 1996, The New England journal of medicine.